Barry Greene, President at Alnylam Pharma, holds 46.94K shares in SAGE Therapeutics (Ticker: SAGE), holds 13.61K shares in Karyopharm Therapeutics (Ticker: KPTI), holds 73.50K shares in Alnylam Pharma (Ticker: ALNY). Most recently, Barry Greene Bought ― shares of SAGE Therapeutics on Nov 15, 2022 for an estimated value of 499.96K.